Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
Clinical trial NCT01362322 · COMPLETED
Trial details
- NCT number
- NCT01362322
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-09-03
- Enrollment
- 671
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.